Gables Capital Management Inc. Makes New Investment in Astera Labs, Inc. $ALAB

Gables Capital Management Inc. bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 2,800 shares of the company’s stock, valued at approximately $1,352,000.

A number of other large investors also recently made changes to their positions in ALAB. Royal Bank of Canada increased its holdings in Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after purchasing an additional 95,409 shares during the last quarter. AQR Capital Management LLC grew its position in shares of Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares during the period. Empowered Funds LLC grew its position in shares of Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after buying an additional 4,183 shares during the period. First Trust Advisors LP increased its stake in shares of Astera Labs by 102.0% in the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after acquiring an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. increased its stake in shares of Astera Labs by 54.9% in the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

ALAB has been the topic of several recent analyst reports. JPMorgan Chase & Co. lifted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Evercore restated an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. TD Cowen lowered their target price on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research note on Wednesday, August 5th. Zacks Research upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Finally, Needham & Company LLC lifted their price target on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Stock Down 5.2%

NASDAQ:ALAB opened at $303.44 on Wednesday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The business has a 50 day moving average price of $356.72 and a two-hundred day moving average price of $242.75. The company has a market cap of $52.64 billion, a P/E ratio of 150.22 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter in the prior year, the company posted $0.44 earnings per share. The firm’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total value of $3,276,963.90. Following the completion of the transaction, the director owned 5,292 shares in the company, valued at $1,928,140.20. This trade represents a 62.96% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the transaction, the director owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 631,979 shares of company stock valued at $215,479,247. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.